Profound Medical Corp reports results for the quarter ended September 30 - Earnings Summary
08/11/2024 21:04
* Profound Medical Corp PRN.TO reported a quarterly
adjusted
loss of 38 cents per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of -26 cents. The mean expectation of four analysts for the
quarter was for a loss of 29 cents per share. Wall Street
expected results to range from -32 cents to -26 cents per share.
* Revenue rose 63.9% to $2.83 million from a year ago;
analysts
expected $2.88 million.
* Profound Medical Corp's reported EPS for the quarter was a
loss
of 38 cents.
* The company reported a quarterly loss of $9.36 million.
* Profound Medical Corp shares had risen by 14.8% this
quarter and
gained 11.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 2.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is "buy."
Wall Street's median 12-month price target for Profound Medical
Corp is 16.06
This summary was machine generated from LSEG data November 8 at
09:04 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.29 -0.38 Missed
Jun. 30 2024 -0.29 -0.28 Beat
Mar. 31 2024 -0.27 -0.26 Beat
Dec. 31 2023 -0.32 -0.42 Missed